Background and objectives Disorders of mineral metabolism are more common in African Americans with CKD than in European Americans with CKD. Previous studies have focused on the differences in mineral metabolism by self-reported race, making it difficult to delineate the importance of environmental compared with biologic factors.
Introduction
Disorders of mineral metabolism are common among patients with CKD. Compared with European Americans with CKD, African Americans with CKD have a higher prevalence of hypocalcemia, hyperphosphatemia, secondary hyperparathyroidism and vitamin D deficiency, independent of kidney function and other clinical characteristics (1) . Factors that are likely to contribute to the increased burden of disordered mineral metabolism in African Americans with CKD compared with European Americans with CKD include differences in diet, physical activity, access to health care, and biologic variability in bone and mineral homeostasis (2) (3) (4) . Disentangling the importance of biologic factors from environmental factors in disordered mineral metabolism is challenging. However, genetic admixture analysis is one method that can be used to investigate the degree to which observed differences in a given trait are due to genetic (biologic) factors (5) .
In this study, we used estimates of genetic African ancestry derived from genetic admixture analysis among African Americans enrolled in the Chronic Renal Insufficiency Cohort (CRIC) study (a prospective study of people with CKD) to test the hypothesis that a higher percentage of African ancestry was independently associated with abnormalities in mineral metabolism markers. Furthermore, we examined the extent to which these associations might explain differences in mineral metabolism in African Americans compared with European Americans.
Materials and Methods
The CRIC study is an ongoing prospective observational cohort study of patients with mild to moderate CKD that was established to examine risk factors for chronic kidney and cardiovascular disease progression (6, 7) . A total of 3939 participants aged 21-74 years Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
were initially enrolled from seven clinical centers (representing 13 recruiting sites) located in Ann Arbor, Michigan; Baltimore, Maryland; Chicago, Illinois; Cleveland, Ohio; New Orleans, Louisiana; Philadelphia, Pennsylvania; and Oakland, California. All participants completed a baseline visit, during which demographic characteristics, medical history, diet history, current medications, anthropomorphic measurements, and plasma, urine, and DNA samples were obtained. The study protocol was approved by the institutional review board at each of the recruiting sites, and all participants provided written informed consent.
Participants were asked to report their race as black, white, or other, and their ethnicity as either Hispanic or non-Hispanic. Diabetes was defined as having an established medical history of diabetes, current or previous use of diabetes medications, or documented laboratory evidence of diabetes (i.e., two episodes of a random plasma glucose .200 mg/dL in conjunction with classic symptoms or a fasting plasma glucose level .126 mg/dL). Annual household income, highest level of education achieved, and employment status were used as indexes of socioeconomic status.
Laboratory and Dietary Characteristics
All laboratory characteristics reported in this study were from the baseline study visit and were measured at a single laboratory. Serum and urine phosphorus, calcium, and creatinine and serum total alkaline phosphatase were measured with standard assays. Parathyroid hormone (PTH) concentrations were measured using an intact assay (Scantibodies, Santee, California). Fibroblast growth factor 23 (FGF23) concentrations were measured using a second-generation, carboxy-terminal assay (Immutopics, Santa Clara, California). eGFR was calculated using the CRIC study equation (8) . Urine fractional excretion of phosphorus and calcium were calculated as follows: ([urine analyte 3 serum creatinine] 4 [serum analyte 3 urine creatinine]) 3 100%.
The National Cancer Institute Diet History Questionnaire (DHQ) was used to assess diet (9) . The DHQ is a food frequency questionnaire designed to assess usual dietary intake by recording the frequency of consumption and portion size eaten for 124 food items over the preceding year. DHQs were analyzed for daily nutrient intake using DietCalc software (http://appliedresearch.cancer.gov/ DHQ/dietcalc).
Estimation of Percentage Genetic African Ancestry
Genetic admixture analysis is one method used to investigate the degree to which observed differences in a given trait are due to genetic (biologic) versus environmental exposures. This technique relies on the principle that individuals can be classified into gradations of commonly identified ethnic groups (e.g., European, African) by using ancestry-informative single nucleotide polymorphisms to quantify the proportion of an individual's genome that is of a given ancestral origin (10) . These data can then be utilized to examine the potential associations between a specific continental ancestral group, for example, within an admixed group such as African Americans, and phenotypes of interest. The finding of such an association between percentage African ancestry within the same ethnic group (i.e., black) would then strongly support a genetic basis for the differential expression of a trait among racial groups.
A total of 1348 HapMap3-based ancestry-informative markers (AIMs) that were available on the IBC Illumina chip array panel were selected to determine percentage genetic African ancestry in African American participants (a full listing of markers used can be found in Supplemental Table 1 ). Quality control metrics for the Illumina based BeadChip genotype results included testing for HardyWeinberg Equilibrium, sex concordance, excess heterozygosity, call rates, and relatedness, resulting in 1053 AIMs that were used for this analysis. An admixture model was employed using the software Structure to derive global European and African continental genetic ancestry measures, as previously reported (11) . Previous studies have established that even small subsets of fewer than 300 AIMs can reliably correlate ancestry to matching reference panels (r=0.99) (12, 13) . We found 96.7% and 98.8% concordance rate between self-reported white and black race with our genotype-derived European and African ancestry classifications, respectively (11) .
Statistical Analyses
Participant characteristics at the time of entry into the CRIC study were compared between African Americans and European Americans overall using t tests or the Wilcoxon rank sum test for continuous variables as appropriate, and chi-squared tests for categorical variables. Among African Americans, characteristics were also compared across quartiles of percentage African ancestry using linear tests of trend for normally distributed continuous variables, the Kruskal-Wallis test for nonnormally distributed continuous variables and CochranArmitage tests of trend for categorical variables. Generalized linear models were used to examine the association between percentage African ancestry and markers of mineral metabolism. Multivariable models were fitted to adjust for potential confounders and factors significantly (P,0.05) associated with percentage African ancestry on univariate analysis. As the values for alkaline phosphatase, FGF23, PTH, 24-hour urine calcium excretion, and fractional excretion of calcium were not normally distributed, models were fitted using natural log-transformed values, which were then transformed back into the conventional scale for clarity of presentation. In the primary analyses, we excluded individuals with implausible values for 24-hour urinary creatinine excretion of ,350 or .3500 mg/day. In sensitivity analyses, we modeled urine mineral excretion as 24-hour urine phosphorus or calcium excretion indexed to urine creatinine excretion (expressed as milligram of phosphorus or calcium excretion per gram of creatinine excretion) and examined models excluding individuals with very low eGFR (,30), and also used stricter criteria for excluding individuals with low 24-hour urine creatinine excretion (,700 mg/day versus #350 mg/day). Two-tailed P values ,0.05 were considered statistically significant in all analyses. SAS version 9.4 statistical software (SAS Institute, Cary, NC) was used to conduct all analyses.
Results

Study Population
Of the 3939 CRIC study participants, we excluded 395 participants with missing data on percent African ancestry, 131 participants who identified themselves as "other race," and 400 participants who identified themselves as being of Hispanic ethnicity (whether or not they self-reported black race), leaving 3013 participants in the final analyzed sample (1523 European Americans and 1490 African Americans by self-reported race; Figure 1 ). Of these, 538 participants (18%) did not complete dietary questionnaires or had questionnaires excluded because of extreme values for total energy intake (i.e., ,600 kcal or .4000 kcal for women and ,800 kcal or .5000 kcal for men), leaving 2475 participants available for analyses of dietary data. For analyses involving 24-hour urine data, 158 individuals (5%) were excluded because of implausible 24-hour urine results defined as total urine creatinine excretion ,350 mg or .3500 mg per 24 hours. Table 1 compares the demographic, clinical, and laboratory characteristics of participants by self-reported race (African Americans versus European Americans) and by quartiles of percent African ancestry; the latter only in participants who self-reported African-American race. The mean percent African ancestry in African-American participants was 77.669.1%. Compared with European Americans, African Americans were younger, more likely to be female, had higher body mass index (BMI) and waist circumference, were more likely to be current smokers, had higher systolic and diastolic blood pressure, were more likely to have a history of diabetes, cardiovascular disease and hypertension, were more likely to have lower annual family income and lower educational achievement, and had lower eGFR and higher urine albumin-to-creatinine ratio. Lower educational achievement and lower annual income were significantly associated with a higher percentage of African ancestry in participants who self-reported African American race. There were no differences in eGFR or urine albumin-to-creatinine ratio across quartiles of African ancestry.
When comparing differences in diet by self-reported race, African Americans reported higher daily energy intake, lower percent energy intake from fat and protein, higher percent energy from carbohydrates, lower calcium intake per day, and lower daily phosphorus intake compared with European Americans (Table 2) . Among African American participants, a higher percentage of African ancestry was associated with lower energy intake from fat and higher energy intake from carbohydrates. Calcium and phosphorus intake did not vary significantly among quartiles of African ancestry.
Self-reported Race, Percent African Ancestry and Markers of Mineral Metabolism
African Americans had higher blood concentrations of phosphorus, alkaline phosphatase, FGF23, and PTH, lower 24-hour urinary excretion of calcium and phosphorus, and lower urinary fractional excretion of calcium and phosphorus compared with European Americans (Table 3) , as has been reported previously (1, 14, 15) . In participants who self-reported African-American race, mean 24-hour urinary phosphorus excretion was lower with higher percentage of African ancestry (P trend ,0.01). Mean urinary fractional excretion of phosphorus was also lower with higher percentage of African ancestry, but this difference was not statistically significant (P=0.13). The remaining markers of mineral metabolism did not vary significantly according to percentage of African ancestry. Differences in serum phosphorus, 24-hour urinary phosphorus excretion and fractional excretion of phosphorus by self-reported race and percentage African ancestry are depicted graphically in Figure 2 . Percentage African ancestry was inversely associated with 24-hour urinary phosphorus excretion after adjustment for age, female sex and baseline eGFR (P,0.001) and remained significant after further adjustment for BMI, diabetes, measures of socioeconomic status, dietary phosphorus intake, and serum phosphorus concentrations (P,0.001; Table 4 ). In the fully adjusted model, each additional 10% of African ancestry was associated with 39.6 mg lower urinary phosphorus excretion per day. After adjustment for age, female sex, and eGFR, the inverse association of African ancestry with urinary fractional excretion of phosphorus became statistically significant (P,0.01). The magnitude and statistical strength of this association did not change meaningfully after further adjustment for BMI, diabetes, socioeconomic status, diet phosphorus intake and serum phosphorus concentrations. In the final model, each additional 10% of African ancestry was associated with an absolute 1.1% lower urinary fractional excretion of phosphorus (P=0.01). These results did not differ when urinary phosphorus excretion was expressed per gram of urine creatinine, or when we excluded individuals with very low eGFR (,30) or when we used stricter criteria for excluding individuals with low 24-hour urine creatinine excretion (data not shown).
Discussion
We found that greater African ancestry was independently associated with lower 24-hour urinary phosphorus excretion and lower fractional excretion of phosphorus among African Americans with CKD. Additionally, we observed similar differences in urinary phosphorus excretion when comparing African Americans to European Americans. These findings suggest that genetic variability may partly explain racial differences in urinary phosphorus excretion between African Americans and European Americans.
Previous studies have shown lower mean 24-hour urinary phosphorus excretion in African Americans compared with European Americans (16) (17) (18) (19) . However, selfreported race is tightly linked to socioeconomic disparities, such as inadequate access to healthy foods or medical care, which might confound these associations, making it difficult to determine to what extent previously observed racial differences in urine phosphorus excretion reflected biologic versus environmental effects. Our finding that greater African ancestry was independently associated with lower 24-hour urinary phosphorus excretion and fractional excretion of phosphorus suggest that racial differences in urinary phosphorus excretion are at least partially due to genetic variability and not simply due to differences in dietary intake.
In steady-state conditions, differences in 24-hour urine phosphorus excretion most likely represent differences in gastrointestinal phosphorus absorption. Importantly, daily phosphorus consumption did not differ across quartiles of African ancestry among African-American CRIC study participants. Furthermore, the significant association of higher African ancestry with lower 24-hour urine phosphorus excretion remained after adjustment for dietary intake of phosphorus, making it less likely that differences in phosphorus consumption could explain our finding. Biologic differences in gut phosphorus absorption seem more plausible. Although primarily absorbed through passive paracellular mechanisms, dietary phosphorus is also absorbed via sodium-phosphorus cotransporters through mechanisms actively regulated by vitamin D (20) . A previous study showed lower gut calcium absorption in black women treated with oral calcitriol compared with white women treated with oral calcitriol (21), suggesting relative gut resistance to the action of calcitriol in black individuals. Since calcitriol also stimulates phosphorus absorption in the gut, it is possible that the inverse association of African ancestry with urinary phosphorus excretion represents biologic differences in the sensitivity of sodium-phosphorus cotransporters to the activated form of vitamin D in gut epithelial cells. Unraveling the reasons why individuals with higher African ancestry had lower 24-hour urinary phosphorus excretion is necessary to determine the potential clinical applications of our findings. Urinary fractional excretion of phosphorus is a marker of renal tubular phosphorus processing. The primary hormones involved in regulating fractional excretion of phosphorus are PTH and FGF23. Thus, it is interesting that lower fractional excretion of phosphorus was associated with greater African ancestry in multivariable-adjusted models despite an absence of differences in PTH or FGF23 across quartiles of African ancestry. For any given level of PTH or FGF23, individuals with greater African ancestry had lower fractional excretion of phosphorus, suggesting that another explanation for our observations may be potential resistance to the phosphaturic stimuli of PTH and FGF23 at the level of the renal tubules. Though speculative, it is possible that these findings represent an adaptive advantage for conserving bone mineral density in African Americans that becomes maladaptive in states of phosphorus overload, such as CKD or high dietary phosphorus intake, and thereby impairs the excretion of excess phosphorus.
We did not observe a significant association of African ancestry with other markers of mineral metabolism among African Americans despite marked differences between African Americans and European Americans with regard to these analytes. Although these findings cannot rule out a genetic component to racial differences in these other markers of mineral metabolism, they suggest that factors such as diet, bone turnover, and diurnal variation, may play more important roles. This is consistent with a previous finding from the CRIC study in which differences in concentrations of serum phosphorus between African Americans and European Americans depended on socioeconomic status, indicating that environmental factors at least partly influence differences in systemic phosphorus processing by race (14) . This study had a number of advantages over previous studies, including standardized collection of baseline data, and a large, multiracial cohort of individuals with CKD together with estimates of genetic African ancestry and markers of mineral metabolism, enabling us to report novel associations of African ancestry with urinary phosphorus excretion. However, this study also has limitations. Multiple factors impact the measures of mineral metabolism analyzed in the current study. Thus, it is possible that associations of African ancestry with markers of mineral metabolism were missed because of insufficient power to detect relatively small measures of effect. Because of important variations in ancestry-informative markers among different African subgroups, the results of the current study might only be informative for the African subgroups genotyped in this study and might not be applicable to all African ancestry subgroups. Although associations of African ancestry with 24-hour urinary phosphorus excretion were robust to adjustment for diet phosphorus intake, the diet instrument used to capture estimated phosphorus intake in the CRIC study probably had incomplete ascertainment of total phosphorus intake in study participants because of the high prevalence of phosphorus-based food additives in the United States food supply. We did not have any information on Klotho expression, precluding us from examining whether differences in Klotho might account for differences in urinary phosphorus excretion according to African ancestry.
In summary, greater African ancestry was independently associated with lower 24-hour urinary phosphorus excretion and fractional excretion of phosphorus in African American participants of the CRIC study. These findings support the notion that, in addition to environmental factors, racial differences in urine phosphorus excretion observed in this and previous studies are partly due to genetic factors. Identifying causal genetic loci that could account for these differences should provide important new insights into the biologic factors underlying systemic phosphorus handling, particularly with respect to intestinal and renal phosphorus handling.
